SCP-4993
Safe
~
medium confidence
SCP-4993
Expected annual
$6.8M
One-time setup
$8.2M
Annual recurring
$6.7M
Personnel
20
Estimated one-time startup CAPEX of $8,225,000 driven by archive construction, lab setup, and initial R&D; recurring annual operating costs about $6,690,125/yr driven primarily by pediatric subject program, amnestic administration, security staffing, and Site-41 overhead.
One-Time Capital Costs
Total: $8.2M
Annual Recurring Costs
Total: $6.7M/yr
Cost Scenarios
📊
Baseline
(baseline)
$6.7M/yr
Normal operational year with routine viewings, scheduled maintenance, and no major incidents.
routine_viewings
scheduled_maintenance
no_major_incident
🚨
Minor Incident
$7.5M/yr
Localized incident (medical adverse event or small containment problem) requiring emergency response, extra amnestic doses, and legal/PR activity.
medical_emergency
small_containment_event
localized_legal_response
🚨
Major Breach
$14.7M/yr
Significant containment breach or public exposure requiring large-scale remediation, legal settlements, program relocation, and major PR/cover operations.
large_scale_breach
public_exposure
major_legal_settlement
Personnel
20 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 10 | [#7] 24/7 armed security covering shifts, leave and quick reaction capability; estimated 8–12 guards, modeled as 10. |
| Archivist / Technician | 3 | [#6] Full-time archivists and technicians to manage specimens, transfers and routine checks; estimated 2–4 staff. |
| Pediatrician | 1 | [#11] Full-time pediatric medical officer for child-subject screening and care. |
| Clinical Psychologist | 2 | [#11, #16] Psychologists for screening, interviews, and follow-up. |
| Nurse | 2 | [#11, #14] Pediatric nurses for dosing/admin and medical monitoring. |
| Administrative Staff / Level-4 approvers | 2 | [#5] Two Level-4 officers required to approve viewings (time allocation handled pro-rata in wages). |
Confidence Notes
The analyst notes provide detailed line-item ranges allowing order-of-magnitude estimates, but many variables (number of viewings, per-dose amnestic complexity, covert legal exposure, and Site-41 overhead allocation) are uncertain, so totals are approximate.